Share
Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward (in English)
Dennis A. Smith
(Author)
·
Alexander Alex
(Author)
·
C. John Harris
(Author)
·
Wiley
· Hardcover
Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward (in English) - Alex, Alexander ; Harris, C. John ; Smith, Dennis A.
$ 147.64
$ 246.07
You save: $ 98.43
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: United Kingdom
(Import costs included in the price)
It will be shipped from our warehouse between
Wednesday, July 31 and
Friday, August 09.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward (in English)"
With a focus on case studies of R&D programs in a variety of disease areas, the book highlights fundamental productivity issues the pharmaceutical industry has been facing and explores potential ways of improving research effectiveness and efficiency. Takes a comprehensive and holistic approach to the problems and potential solutions to drug compound attrition Tackles a problem that adds billions of dollars to drug development programs and health care costs Guides discovery and development scientists through R&D stages, teaching requirements and reasons why drugs can fail Discusses potential ways forward utilizing new approaches and opportunities to reduce attrition
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.
✓ Producto agregado correctamente al carro, Ir a Pagar.
